CVS - CVS Health Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 578.39B
Enterprise Value 3162.31B
Trailing P/E 16.52
Forward P/E 18.36
PEG Ratio (5 yr expected) 12.20
Price/Sales (ttm)0.35
Price/Book (mrq)1.28
Enterprise Value/Revenue 30.72
Enterprise Value/EBITDA 610.94

Trading Information

Stock Price History

Beta (3Y Monthly) 1.08
52-Week Change 3-21.15%
S&P500 52-Week Change 3-0.33%
52 Week High 382.15
52 Week Low 351.72
50-Day Moving Average 356.61
200-Day Moving Average 356.38

Share Statistics

Avg Vol (3 month) 38.47M
Avg Vol (10 day) 39.4M
Shares Outstanding 51.3B
Float 1.3B
% Held by Insiders 10.24%
% Held by Institutions 183.80%
Shares Short (Jul 31, 2019) 422.17M
Short Ratio (Jul 31, 2019) 43.14
Short % of Float (Jul 31, 2019) 41.71%
Short % of Shares Outstanding (Jul 31, 2019) 41.70%
Shares Short (prior month Jun 28, 2019) 419.17M

Dividends & Splits

Forward Annual Dividend Rate 42
Forward Annual Dividend Yield 43.40%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 33.40%
5 Year Average Dividend Yield 42.19
Payout Ratio 456.34%
Dividend Date 3Aug 2, 2019
Ex-Dividend Date 4Jul 24, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 7, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 1.91%
Operating Margin (ttm)4.96%

Management Effectiveness

Return on Assets (ttm)3.98%
Return on Equity (ttm)8.90%

Income Statement

Revenue (ttm)226.05B
Revenue Per Share (ttm)190.76
Quarterly Revenue Growth (yoy)35.20%
Gross Profit (ttm)30.88B
EBITDA 14.83B
Net Income Avi to Common (ttm)4.32B
Diluted EPS (ttm)3.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.53B
Total Cash Per Share (mrq)6.55
Total Debt (mrq)91.92B
Total Debt/Equity (mrq)149.23
Current Ratio (mrq)0.95
Book Value Per Share (mrq)47.18

Cash Flow Statement

Operating Cash Flow (ttm)10.86B
Levered Free Cash Flow (ttm)13.55B